KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Long-Term Investments (2016 - 2023)

Historic Long-Term Investments for Biogen (BIIB) over the last 16 years, with Q4 2025 value amounting to $431.9 million.

  • Biogen's Long-Term Investments changed N/A to $431.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $431.9 million, marking a year-over-year change of. This contributed to the annual value of $431.9 million for FY2025, which is N/A changed from last year.
  • Per Biogen's latest filing, its Long-Term Investments stood at $431.9 million for Q4 2025.
  • Over the past 5 years, Biogen's Long-Term Investments peaked at $1.2 billion during Q2 2023, and registered a low of $100000.0 during Q3 2023.
  • Moreover, its 4-year median value for Long-Term Investments was $903.6 million (2021), whereas its average is $823.8 million.
  • In the last 5 years, Biogen's Long-Term Investments soared by 2186.4% in 2022 and then tumbled by 9998.84% in 2023.
  • Biogen's Long-Term Investments (Quarter) stood at $892.0 million in 2021, then dropped by 20.89% to $705.7 million in 2022, then crashed by 99.99% to $100000.0 in 2023, then skyrocketed by 431800.0% to $431.9 million in 2025.
  • Its Long-Term Investments stands at $431.9 million for Q4 2025, versus $100000.0 for Q3 2023 and $1.2 billion for Q2 2023.